Evidence map›Paper›PMID 39651061›Full record

ArticleBlood cell therapy2024

Impact of the COVID-19 outbreak on the field of hematopoietic cell transplantation in the Asia-Pacific region: APBMT Activity Survey 2020/2021.

Minako Iida, Aloysius Ho, Xiao Jun Huang, Kaiyan Liu, Meng Lv, He Huang, Yachiyo Kuwatsuka, Joon Ho Moon, Yoon Seok Choi, Jong Wook Lee and 34 more

Erratum issuedAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood cell therapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

44 authors.

Minako IidaDepartment of Promotion for Blood and Marrow Transplantation, Aichi Medical University School of Medicine, Nagakute, Japan.
Aloysius HoDepartment of Hematology, Singapore General Hospital, Singapore, Singapore.
Xiao Jun HuangDepartment of Hematology, Peking University Institute of Hematology, Beijing, China.
Kaiyan LiuDepartment of Hematology, Peking University Institute of Hematology, Beijing, China.
Meng LvDepartment of Hematology, Peking University Institute of Hematology, Beijing, China.
He HuangDepartment of Hematology, Zhejian University, Zhejiang, China.
Yachiyo KuwatsukaDepartment of Advanced Medicine, Nagoya University Hospital, Nagoya, Japan.
Joon Ho MoonDivision of Hematology-Oncology, Department of Internal Medicine, Kyungpook National University Hospital, Daegu, Republic of Korea.
Yoon Seok ChoiDepartment of Internal Medicine, Korea University College of Medicine, Seoul, South Korea.
Jong Wook LeeDivision of Hematology, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, South Korea.
Navin KhattryDepartment of Oncology, Tata Medical Center, Navi Mumbai, India.
Kavitha M LakshmiDepartment of Hematology, Christian Medical College Hospital, Vellore, India.
Leonie WilcoxAustralasian Bone Marrow Transplant Recipient Registry (ABMTRR), Sydney, Australia.
Amir Ali HamidiehChildren's Medical Center, Pediatric Center of Excellence, Tehran University of Medical Sciences, Tehran, Iran.
Maryam BehfarChildren's Medical Center, Pediatric Center of Excellence, Tehran University of Medical Sciences, Tehran, Iran.
Bor-Sheng KoDepartment of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Kim Wah HoDepartment of Hematology, Hospital Ampang, Ampang Selangor, Malaysia.
Gin Gin GanDepartment of Medicine, Faculty of Medicine, University of Malaya, Lembah Pantai, Kuala Lumpur, Malaysia.
Udomsak BunworasateDivision of Hematology and Center of Excellence in Translational Hematology, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
Suradej HongengDepartment of Pediatrics, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Usanarat AnurathapanDepartment of Pediatrics, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Tasneem FarzanaDepartment of Clinical Hematology, National Institute of Blood Disease and Bone Marrow Transplantation, Karachi, Pakistan.
Joycelyn SimDepartment of Medicine, Queen Mary Hospital, Hong Kong.
Vincent LeeDepartment of Pediatrics, Prince of Wales Hospital, Hong Kong, Hong Kong.
Man Kit Garret LeungDepartment of Medicine, Queen Mary Hospital, Hong Kong.
Phu Chi DungStem Cell Transplantation Department, Blood Transfusion and Hematology Hospital, Ho Chi Minh, Vietnam.
Van Man HuynhStem Cell Transplantation Department, Blood Transfusion and Hematology Hospital, Ho Chi Minh, Vietnam.
Wasantha RathnayakeBone Marrow Transplant Unit, Nawaloka Hospital PLC, Colombo, Sri Lanka.
Prasad AbeysingheDepartment of Oncology, National Cancer Institute, Maharagama, Sri Lanka.
Marjorie Rose BravoSt Luke's Medical Center Quezon City, IM Hematology/Blood and Marrow Transplant, Quezon, the Philippines.
Teresita DumagayDepartment of Medicine, National Kidney and Transplant Institute, Quezon, the Philippines.
Aye Aye GyiDepartment of Clinical Hematology, North Okkalapa General Hospital, Yangon, Myanmar.
Damai SantosaDivision of Hematology Medical Oncology, Department of Internal Medicine, Dr. Kariadi Hospital/Diponegoro University, Semarang, Indonesia.
Desta ArdiniDivision of Hematology Medical Oncology, Department of Internal Medicine, Dr. Kariadi Hospital/Diponegoro University, Semarang, Indonesia.
Bishesh Sharma PoudyalClinical Hematology and Bone Marrow Transplant Unit, Civil Service Hospital, Kathmandu, Nepal.
Mafruha AkterDepartment of Hematology and BMT, Dhaka Medical College and Hospital, Dhaka, Bangladesh.
Khishigjargal BatshkhBone and Marrow Transplantation Team, Hematology Department, National First Central Hospital of Mongolia, Ulaanbaatar, Mongolia.
Mikhail DrokovDepartment of Hemoblastosis Chemotherapy and Bone Marrow and Hematopoietic Stem Cell Transplantation, National Medical Research Center for Hematology, Moscow, Russian Federation.
Chi-Cheng LiCenter of Stem Cell and Precision Medicine, Hualien Tzu Chi Hospital, Taiwan.
Shinichiro OkamotoDivision of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
Alok SrivastavaDepartment of Hematology, Christian Medical College Hospital, Vellore, India.
Anthony DoddsSt. Vincent's Pathology, St. Vincent's Health Network, Sydney, and Australasian Bone Marrow Transplant Recipient Registry (ABMTRR), Sydney, Australia.
Yoshiko AtsutaJapanese Data Center for Hematopoietic Cell Transplantation (JDCHCT), Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Nagakute, Japan.
Registry Committee of the Asia-Pacific Blood and Marrow Transplantation Group (APBMT)

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

COVID-19 became a global pandemic in 2020 and significantly affected the activity of hematopoietic cell transplants (HCT) worldwide. Despite these challenges, a total of 28,793 transplants, including 18,518 allogeneic and 10,275 autologous transplants, were performed in 719 facilities in 2020 in the Asia-Pacific (AP) region. This represented a 5.1% increase in allogeneic transplants and a 3.1% increase in autologous transplants, an overall increase of 4.4% compared to the numbers in 2019. With respect to the donor source, haploidentical transplants increased significantly by 18.6%, related transplants by 8.8%, and cord blood transplants (CBT) by 9.2%. However, the number of unrelated transplants, excluding CBT, decreased for the first time by 8.2%. As a result, COVID-19 facilitated the growth of haploidentical transplants due to cross-border restrictions. Regarding the changes in the total number of transplants by country/region in 2020, it increased by 2,048 transplants in China, followed by Japan (210 transplants) and Korea (230 transplants); however, 14 of the 22 countries and regions decreased their number of transplants in 2020 compared to the previous year. There was no correlation between the increase or decrease in the number of transplants in 2020 and the Gross National Income (GNI) per capita of each country/region in 2020, as well as Domestic General Government Health Expenditure as a percentage of General Government Expenditure (GGHE-D/GGE). In 2021, the total number of transplants in this region was 34,754. With the exception of a few countries/regions that decreased the number of transplants in 2020, most countries/regions have started to see a recovery in 2021. The COVID-19 pandemic significantly affected the supply chain and logistics involved in HCT rather than its numbers; however, we have found ways to overcome logistical challenges to carry out transplant medicine without delay, even under these circumstances.

Indexed as

Asia-Pacific regionCOVID-19hematopoietic cell transplantationnumber of transplants

Identifiers

PMID39651061
PMCPMC11620985

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.